Abivax ABVX
NASDAQ ABVX
$96.85 +5.79 (+6.36%)
At close: Sep 28, 2026 · 4:00 PM EDT

Abivax (ABVX) Other Operating Expenses (2024 - 2026)

Updated

Abivax (ABVX) recorded Other Operating Expenses of -$3.35 million in Q2 2026, compared with -$762,941 a year earlier.

Analysis

Abivax (ABVX) Other Operating Expenses (2024 - 2026) Analysis & Trends

On a TTM basis, Abivax's Other Operating Expenses came in at -$9.67 million as of Jun 30, 2026; for FY2025, it came in at -$5.87 million.

  • Across earlier years, Other Operating Expenses came in at -$6.44 million in FY2024 and -$6.96 million in FY2023.
  • The Q2 2026 figure is the lowest quarterly Other Operating Expenses in data going back to Q1 2024.
  • Per Business Quant, the preceding three quarters came in at -$2.05 million (Q1 2026), -$2.12 million (Q4 2025) and -$2.15 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 653.54 Bn 572.07 Bn 17.26 Bn
2 AbbVie 467.01 Bn 440.17 Bn 12.70 Bn
3 Merck 367.16 Bn 321.59 Bn 12.21 Bn
4 Novartis Ag 277.56 Bn 233.43 Bn 11.24 Bn
5 Astrazeneca 258.23 Bn 231.79 Bn 12.86 Bn
6 Amgen 224.14 Bn 179.54 Bn 7.24 Bn
7 Gilead Sciences 187.30 Bn 161.42 Bn 6.22 Bn
8 Pfizer 163.47 Bn 110.41 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.31 Bn 105.31 Bn 2.84 Bn
10 Abivax 7.15 Bn 7.15 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -3.35 Mn
Mar 31, 2026 -2.05 Mn
Dec 31, 2025 -2.12 Mn
Sep 30, 2025 -2.15 Mn
Jun 30, 2025 -762,940.83
Mar 31, 2025 -904,620.62
Dec 31, 2024 -931,815.19
Sep 30, 2024 -936,781.24
Jun 30, 2024 -2.43 Mn
Mar 31, 2024 -2.15 Mn
API Access

Abivax Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=ABVX&period=max&api_key=YOUR_API_KEY